HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.

Abstract
PF9601N [N-(2-propynyl) 2-(5-benzyloxyindol) methylamine] is a non-amphetamine type MAO-B inhibitor that has shown neuroprotective properties in vivo using different experimental models of Parkinson's disease. The mechanisms underlying its neuroprotective effects are poorly understood, but appear to be independent of MAO-B inhibition. We have studied its neuroprotective properties using the human SH-SY5Y dopaminergic cell line exposed to 1-methyl-4-phenylpyridinium (MPP(+)), a cellular model of Parkinson's disease. PF9601N pre-treatment significantly reduced MPP(+)-induced cell death and decreased the activation of one of the main executioner caspases, caspase-3. MPP(+) induced stabilization of transcription factor p53, which led to increased levels of this transcription factor, its nuclear translocation and transactivation of p53 response elements. PF9601N prevented this increase, thus reducing its transcriptional activity. Additional results showed that p53 may mediate its pro-apoptotic actions through caspase-2 under our experimental conditions. PUMA-alpha may also contribute to the p53-induced cell death. Since PF9601N significantly reduced MPP(+)-induced caspase-2 activity and PUMA-alpha levels, this reduction may lead to increased cell survival. Thus, PF9601N is a novel molecule with an apparently novel mechanism of action which has a promising potential as a therapeutic agent in the treatment of neurodegenerative diseases.
AuthorsElisenda Sanz, Albert Quintana, Valentina Battaglia, Antonio Toninello, Juan Hidalgo, Santiago Ambrosio, Massimo Valoti, Jose Luis Marco, Keith F Tipton, Mercedes Unzeta
JournalJournal of neurochemistry (J Neurochem) Vol. 105 Issue 6 Pg. 2404-17 (Jun 01 2008) ISSN: 1471-4159 [Electronic] England
PMID18331475 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Indoles
  • Monoamine Oxidase Inhibitors
  • N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine
  • Neuroprotective Agents
  • Tumor Suppressor Protein p53
  • Monoamine Oxidase
  • 1-Methyl-4-phenylpyridinium
Topics
  • 1-Methyl-4-phenylpyridinium (toxicity)
  • Animals
  • Apoptosis (drug effects, physiology)
  • Cell Death (drug effects, physiology)
  • Cell Line, Tumor
  • Humans
  • Indoles (pharmacology, therapeutic use)
  • Monoamine Oxidase (metabolism)
  • Monoamine Oxidase Inhibitors (toxicity)
  • Neurons (drug effects, physiology)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Rats
  • Signal Transduction (drug effects, physiology)
  • Tumor Suppressor Protein p53 (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: